LANCL1 as the Key Immune Marker in Neuropathic Pain
Objective. This study is to explore key immune markers and changes of immune microenvironment in neuropathic pain (NeuP). Method. The data sets of GSE145199 and GSE145226 in Gene Expression Omnibus (GEO) database was used to analyze, and the key immune markers were verified by GSE70006 and GSE91396,...
Saved in:
Main Authors: | Yu Shi, XueFei Zhang, Qian Fang, Hongrui Zhan, Xianglong Wang, Xiyan Huang, Tao Fan, Wei Liu, Wen Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Neural Plasticity |
Online Access: | http://dx.doi.org/10.1155/2022/9762244 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Maladaptive Plasticity and Neuropathic Pain
by: Xiang-Yao Li, et al.
Published: (2016-01-01) -
Use of Methadone for Neuropathic Pain
by: Dwight Moulin
Published: (2003-01-01) -
Methadone in the Treatment of Neuropathic Pain
by: Bruno Gagnon, et al.
Published: (2003-01-01) -
An atlas of neuropathic pain-associated molecular pathological characteristics in the mouse spinal cord
by: Fu-Lu Dong, et al.
Published: (2025-01-01) -
Impaired Autophagy of GABAergic Interneurons in Neuropathic Pain
by: Yuhua Yin, et al.
Published: (2018-01-01)